BIIB059, a Humanized Monoclonal Antibody Targeting BDCA2 on Plasmacytoid Dendritic Cells (PDC), Shows Dose-Related Efficacy in the Phase 2 Lilac Study in Patients (PTS) with Active Cutaneous Lupus Erythematosus (CLE)

Results

Title:	BIIB059, a Humanized Monoclonal Antibody Targeting BDCA2 on Plasmacytoid Dendritic Cells (PDC), Shows Dose-Related Efficacy in the Phase 2 Lilac Study in Patients (PTS) with Active Cutaneous Lupus Erythematosus (CLE)
Authors :	Werth, Victoria P.; ...; Radunović, Goran L ; ...; (broj koautora 17)
Issue Date:	2020
Publication:	Annals of the rheumatic diseases (Annual European Congress of Rheumatology (EULAR), Jun 03 2020)
ISSN:	0003-4967 Annals of the Rheumatic Diseases Search Idenfier
Publisher:	London : BMJ
Type:	Conference Paper
Collation:	vol. 79 br. Suppl 1 str. 120-121
DOI:	10.1136/annrheumdis-2020-eular.5743
WoS-ID:	000555905000192
URI:	https://enauka.gov.rs/handle/123456789/797164
URL:	https://ard.bmj.com/content/79/Suppl_1/120
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

1
OpenCitations

16
WEB OF SCIENCE^TM

Altmetric

Dimensions

Unpaywall

Google Scholar^TM